Generic drug maker Ozon Pharmaceuticals raised 3.45 billion rubles during an initial public offering on the Moscow Stock Exchange, including a base amount of 3 billion rubles and a stabilization package of 450 million rubles, according to a statement on the pharmaceutical company’s website.
Author:
https://rb.ru/author/ntihonov/
Subscribe to RB.RU on Telegram
The placement was carried out at a price of 35 rubles per share; This is the upper limit of the IPO price range. The capitalization of the company reached 38.5 billion rubles.
It is reported that within the framework of the placement the group attracted institutional investors, as well as more than 40 thousand private investors.
Ozon Pharmaceuticals will use the funds received during the IPO to expand the line of generic and biosimilar drugs, as well as launch new production facilities.
Trading in the company’s shares will begin on October 17 at around 16:00 Moscow time under the symbol OZPH. The Moscow Stock Exchange included shares of Ozon Pharmaceuticals in the first level of the list of securities admitted to trading.
Ozon Pharmaceuticals announced plans to hold an initial public offering on the Moscow Stock Exchange on October 8. According to the results of the first six months of 2024, the company’s revenue amounted to 12.6 billion rubles, and net profit – 2.9 billion rubles.
Author:
Nikolai Tikhonov
Source: RB
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
